Risk of severe COVID-19 infection in kidney transplant recipients
Retrospective 63 COVID+ kidney transplant recipients, showing significantly lower vitamin D levels before infection in patients requiring ICU admission.
Sacristán et al., 12 Nov 2021, peer-reviewed, 9 authors.
Abstract: Journal Pre-proof
RISK OF SEVERE COVID-19 INFECTION IN KIDNEY
TRANSPLANT RECIPIENTS
Pilar Galindo Sacristán , Elena Clavero Garcı́a ,
Elisa Berta Pereira , Almudena Pérez Marfil ,
Marı́a José Torres Sánchez , José Manuel Osorio Moratalla ,
Carmen De Gracia Guindo , Marı́a Carmen Ruiz Fuentes ,
Antonio Osuna Ortega
PII:
DOI:
Reference:
S0041-1345(21)00806-X
https://doi.org/10.1016/j.transproceed.2021.08.060
TPS 30693
To appear in:
Transplantation Proceedings
Please cite this article as: Pilar Galindo Sacristán , Elena Clavero Garcı́a , Elisa Berta Pereira ,
Almudena Pérez Marfil ,
Marı́a José Torres Sánchez ,
José Manuel Osorio Moratalla ,
Carmen De Gracia Guindo , Marı́a Carmen Ruiz Fuentes , Antonio Osuna Ortega , RISK OF SEVERE COVID-19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS, Transplantation Proceedings
(2021), doi: https://doi.org/10.1016/j.transproceed.2021.08.060
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
© 2021 Published by Elsevier Inc.
TITLE: “RISK OF SEVERE COVID-19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS”
AUTHORS: Pilar Galindo Sacristán1, Elena Clavero García1, Elisa Berta Pereira Pérez1, Almudena Pérez Marfil1, María José
Torres Sánchez1, José Manuel Osorio Moratalla1, Carmen De Gracia Guindo1, María Carmen Ruiz Fuentes1, Antonio Osuna
Ortega1.
1 Department of Nephrology. Virgen de las Nieves Universitary Hospital. Granada. Spain
EMAIL ADDRESSES:
pgalindosacristan@gmail.com (Pilar Galindo Sacristán)
elena.clavero.sspa@juntadeandalucia.es (Elena Clavero García)
elisapereirap@gmail.com (Elisa Berta Pereira Pérez)
aperezmarfil@yahoo.es (Almudena Pérez Marfil)
mjtosan@gmail.com (María José Torres Sánchez)
josem.osorio.sspa@juntadeandalucia.es (José Manuel Osorio Moratalla)
degraciaguindo@gmail.com (Carmen De Gracia Guindo)
mcarmenrf2005@gmail.com (María Carmen Ruiz Fuentes)
aosunaortega@ugr.es (Antonio Osuna Ortega)
INSTITUTION ADDRESS: 2 Fuerzas Armadas AVE, Granada, 18014
INSTITUTION TELEPHONE: +34 958020000
MAIN AUTHOR: Pilar Galindo Sacristán ; pgalindosacristan@gmail.com ; +34626648738
KEY WORDS: COVID, immunosuppression, predictors
GRANT SUPPORT: NO
INTRODUCTION: Despite all efforts, the incidence of severe COVID infection has been high in renal transplant recipients, as
in other groups (elderly, patients with comorbidities or immunosuppression). The detection of any possible predictor of
gravity could improve the early approach in these patients.
PATIENTS AND METHODS: We registered data from renal transplant recipients with SARS-COVID infection in our area
during a year (March 2020-2021). We collected demographics, comorbidity, body mass index, lymphocyte count and
vitamin D level before the diagnosis. We performed statistical analysis using SSPS.20.
RESULTS: Of 63 patients, 57.1% required hospital admission and 14.3% intensive care. The incidence of acute renal failure
was 28.6%. 34.9% developed hyperinflammatory syndrome. 67% had lymphopenia, which was severe in 13.1%...
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit